Seres therapeutics appoints genomic medicine and microbiology pioneer claire m. fraser, ph.d.

Cambridge, mass.--( business wire )--seres therapeutics, inc. (nasdaq: mcrb) today announced the appointment of claire m. fraser, ph.d., to its board of directors. dr. fraser will begin serving on seres' board, effective immediately.

MCRB Ratings Summary

MCRB Quant Ranking